National Institute Of Diabetes And Digestive And Kidney Diseases (niddk)
Clinical trials sponsored by National Institute Of Diabetes And Digestive And Kidney Diseases (niddk), explained in plain language.
-
Promising diabetes delay study halted due to lack of participants
Disease control TerminatedThis study tested a low dose of a drug called ATG to see if it could delay or prevent type 1 diabetes in people at high risk. Only 2 people enrolled, so the study was stopped early. The goal was to measure how long it took for participants to develop full diabetes.
Phase: PHASE2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated May 17, 2026 00:40 UTC
-
Scientists hunt for early warning signs of kidney failure
Knowledge-focused TerminatedThis study aimed to discover substances in blood and urine that could signal kidney damage earlier than current tests. Researchers compared samples from healthy volunteers, people with low fluid levels, those at high risk for kidney failure, and patients with acute kidney failure…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated May 17, 2026 00:28 UTC
-
Cystic fibrosis study aims to unlock disease secrets
Knowledge-focused TerminatedThis study collected blood, tissue, and other samples from people with cystic fibrosis (CF) and their family members during regular clinic visits. The goal was to build a database for future research into how CF affects the body and how different genes influence the disease. Abou…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated May 11, 2026 20:49 UTC